Skip to main content

Together we are beating cancer

Donate now

Cancer type

Showing 12 out of 2908 results
A microscopic image of two lung cancer cells dividing, held together by a very thin bridge of cytoplasm.

With £2m in funding, our scientists will begin clinical trials to see if LungVax could be the world's first preventative lung cancer vaccine. With £2m in funding, our scientists will begin clinical trials to see if LungVax could be the world's first preventative lung cancer vaccine.

by Amal Iman | News | 17 November 2025

17 November 2025

A profile image of a brain taken using an MRI scanner, which is used to diagnose brain tumours in children. The brain appears pink and light blue. The subject's head, face and neck are also visible in a darker blue.
  • Science & Technology
  • Health & Medicine

From brain scans to better treatments

Our researchers have found a way to fully diagnose medulloblastoma, a type of childhood brain tumour, much faster, so doctors can make the best treatment decisions from the start. Our researchers have found a way to fully diagnose medulloblastoma, a type of childhood brain tumour, much faster, so doctors can make the best treatment decisions from the start.

by Emily Farthing | In depth | 13 November 2025

13 November 2025

A pill in a petri dish. The Pill is transparent but contains a compressed black sponge. There is a light blue thread attached to one end.
  • Health & Medicine
  • Science & Technology

Meet the capsule sponge

This sponge on a string could help stop oesophageal cancer – one of the hardest to treat cancers – in its tracks. This sponge on a string could help stop oesophageal cancer – one of the hardest to treat cancers – in its tracks.

by Amal Iman | In depth | 13 November 2025

13 November 2025

A cluster of different sized pink cells seen through a microscope.

Our researchers discovered that EGFR, a molecule produced by our cells, can fuel cancer growth. This breakthrough led to the development of targeted treatments that attack cancer at its source. Our researchers discovered that EGFR, a molecule produced by our cells, can fuel cancer growth. This breakthrough led to the development of targeted treatments that attack cancer at its source.

by Henry Scowcroft | In depth | 13 November 2025

13 November 2025

A plastic bag connected to a small machine.

Our researchers are developing a breath test that could help diagnose stomach cancer sooner, so people get treated faster. Our researchers are developing a breath test that could help diagnose stomach cancer sooner, so people get treated faster.

by Nisharnthi Duggan | Analysis | 13 November 2025

13 November 2025

Squamous epithelial cells of human cervix under the microscope view.
  • Science & Technology
  • Health & Medicine

70 years of progress in cervical cancer research

25 years ago, our scientists showed that nearly all cervical cancers are caused by the human papillomavirus (HPV). But that’s not where our story with cervical cancer research starts, and it certainly isn’t where it ends. 25 years ago, our scientists showed that nearly all cervical cancers are caused by the human papillomavirus (HPV). But that’s not where our story with cervical cancer research starts, and it certainly isn’t where it ends.

by Jacob Smith | In depth | 13 November 2025

13 November 2025

Monte Carlo, Monaco aerial panoramic view.

We are delighted to be the chosen charity for CMB Monaco’s World Children’s Day initiative on 20 November 2025. On this day, CMB Monaco will donate a percentage of all trading commissions to support our vital work into cancers affecting children and young people. We are delighted to be the chosen charity for CMB Monaco’s World Children’s Day initiative on 20 November 2025. On this day, CMB Monaco will donate a percentage of all trading commissions to support our vital work into cancers affecting children and young people.

by Cancer Research UK | 5 November 2025

5 November 2025

A microscopic image showing a tumour sample with different types of cells in different colours. Macrophages (red) are producing HO-1 near blood vessels (green) to keep T cells out of tumour tissue. Many of the blue cells in this image are cancer cells. There are small pockets of T cells highlighted in magenta.

KCL-HO-1i, a new type of chemotherapy "companion drug" that can be taken as a daily pill, could pave the way to more effective cancer treatments with fewer side effects. KCL-HO-1i, a new type of chemotherapy "companion drug" that can be taken as a daily pill, could pave the way to more effective cancer treatments with fewer side effects.

by Tim Gunn | Analysis | 4 November 2025

4 November 2025